20
Sanofi Chimie Gentilly Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their significant offerings is Amisulpride, Finorga S.A.S, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2019-265 - Rev 00
This Chemical Type CEP, issued on March 26, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1490 associated with this CEP further emphasizes